Scientists at the Gladstone Institutes have discovered how to make a new type of cell that is in between embryonic stem cells and adult heart cells, and that may hold the key to treating heart disease. These induced expandable cardiovascular progenitor cells (ieCPCs) can organically develop into heart cells, while still being able to replicate. When injected into a mouse after a heart attack, the cells improved heart function dramatically.
The three types of heart cells — cardiomyocytes, endothelial cells, and smooth muscle cells — created from ieCPCs.
Credit: Yu Zhang, Gladstone Institutes